The landscape of Alzheimer's disease and dementia care has changed significantly since 2023. The FDA approvals of lecanemab (Leqembi, Eisai/Biogen) and donanemab (Kisunla, Eli Lilly) have introduced disease-modifying therapy options for early Alzheimer's disease — along with entirely new administrative workflows that most memory centers were not structured to absorb. Against this backdrop, virtual assistants with dementia center training are becoming an operational necessity.
Neuropsychological Testing Scheduling and Coordination
Neuropsychological evaluation is a cornerstone of dementia diagnosis and staging. Comprehensive neuropsychological batteries — including memory, executive function, language, and processing speed assessments — typically require two to four hours and must be coordinated with neuropsychologists who maintain separate scheduling systems from the neurology clinic.
The Alzheimer's Association's dementia care practice recommendations identify neuropsychological evaluation as an essential component of early-stage assessment and treatment monitoring. Virtual assistants can manage outbound referrals to neuropsychology, confirm appointment scheduling, communicate preparation instructions to patients and families, and ensure that completed neuropsychological reports are linked to the ordering physician's chart. For high-volume memory centers with neuropsychology programs integrated on-site, VAs can manage internal scheduling queues and results routing.
Anti-Amyloid Therapy Prior Authorization: Leqembi and Kisunla
Lecanemab (Leqembi) and donanemab (Kisunla) represent the first approved disease-modifying therapies for early Alzheimer's disease, but their prior authorization requirements are among the most complex in neurology. Medicare coverage under Coverage with Evidence Development (CED) requires enrollment in a CMS-approved registry, amyloid confirmation via PET scan or CSF biomarker analysis, and staging documentation confirming mild cognitive impairment or mild dementia due to Alzheimer's disease.
A 2024 analysis published in JAMA Neurology estimated that administrative preparation for a single lecanemab initiation — including biomarker documentation, PA submission, and CED registry enrollment — required an average of 6.8 clinician and staff hours. Virtual assistants trained in anti-amyloid therapy prior authorization workflows can own the documentation assembly, registry enrollment, PA submission, and insurance communication components — compressing the time-to-first-infusion timeline while freeing clinicians for patient-facing work.
ARIA Monitoring MRI Scheduling
Both lecanemab and donanemab carry risk of amyloid-related imaging abnormalities (ARIA), requiring MRI brain surveillance at defined intervals during the first year of treatment. Missing or delayed ARIA monitoring MRIs creates safety and liability exposure. Virtual assistants can maintain ARIA monitoring registries, generate MRI referrals on protocol-defined schedules, confirm imaging appointments, and flag overdue scans for urgent clinical review.
ADAS-Cog, MMSE, and Longitudinal Cognitive Score Documentation
The Alzheimer's Disease Assessment Scale – Cognitive Subscale (ADAS-Cog) and the Mini-Mental State Examination (MMSE) remain the primary standardized instruments for tracking cognitive change over time. Scores are required for anti-amyloid therapy eligibility determinations, insurance medical necessity documentation, clinical trial enrollment, and disability certification.
Virtual assistants can prepare standardized scoring templates, transcribe scores following clinical administration, and compile longitudinal cognitive score summaries for insurance letters, care conferences, and trial sponsor reporting.
Caregiver Support Resource Coordination
Alzheimer's disease management is inseparable from caregiver support. Memory centers with robust caregiver coordination programs — linking families to Alzheimer's Association chapters, local support groups, respite care programs, and adult day services — achieve better patient outcomes and lower caregiver burnout rates. Virtual assistants can maintain a curated local resource directory, generate tailored resource packets for newly diagnosed families, and schedule caregiver consultations with social work or patient navigation teams.
To build the administrative infrastructure your memory center needs, explore Stealth Agents.
Sources
- Alzheimer's Association. "2024 Alzheimer's Disease Facts and Figures." Alz.org, 2024.
- Centers for Medicare and Medicaid Services. "Monoclonal Antibodies Directed Against Amyloid for Alzheimer's Disease — CED." CMS.gov, 2023.
- van Dyck CH, et al. "Lecanemab in Early Alzheimer's Disease." New England Journal of Medicine, 2023.
- Sims JR, et al. "Donanemab in Early Symptomatic Alzheimer's Disease." JAMA, 2023.